TRVITrevi Therapeutics, Inc.

$12.61+19% 1Y

Is the price fair?

What TRVI's price assumes

Price / book
9.08

Price / book · as of 2026-Q2

Details›
Price / bookas of 2026-Q2
9.08
Market capitalisation142.5 million shares, counted Jul 31, 2026
$1.80B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

On our screens:Most shorted stocks